Investigation of Reported Anaphylaxis Post COVID-19 Vaccination in Subjects with History of Allergies and Anaphylaxis
Background: Two mRNA COVID-19 vaccines, Pfizer-BioNTech and Moderna, are currently approved in the United States, and one viral-vector vaccine, J&J/Janssen, is authorized for limited use. The Vaccine Adverse Event Reporting System (VAERS) database gathers reports of adverse effects, including an...
Saved in:
Published in | Coronaviruses Vol. 4; no. 3 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Bentham Science Publishers
2023
|
Online Access | Get full text |
ISSN | 2666-7967 |
DOI | 10.2174/2666796704666230904150831 |
Cover
Loading…